Brighter's board has decided to prioritize sale over alternative financing regarding the subsidiaries Camanio and Nectarine and its ownership in Accumbo
Brighter AB (Publ) (the Company) announced today that the Board has come to the conclusion that, in the case of the Company’s subsidiaries Camanio and Nectarine, an outright sale of all shares is preferable to a partial sale or finding third party investment. The Company has therefore decided in principle to sell all shares in the wholly owned subsidiaries and the 9% stake in Accumbo. It was also decided that Camanio's subsidiary Bestic AB will be sold separately, with its products for the healthcare sector - BikeAround, Bestic and Giraff as well as distribution agreements for digital